Cytosorbents Corporation

NASDAQ: CTSO · Real-Time Price · USD
1.15
0.01 (0.88%)
At close: Aug 15, 2025, 3:59 PM
1.14
-0.36%
After-hours: Aug 15, 2025, 04:48 PM EDT

Cytosorbents Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-9.75M -15.84M -20.45M -18.4M -25.26M -27.27M -28.51M -23.44M -26.45M -31.17M -32.81M -41.35M -35.56M -29.36M -24.56M -15.93M -10.36M -8.55M
Depreciation & Amortization
1.7M 1.71M 1.74M 2.11M 2.15M 2.16M 2.03M 1.51M 1.33M 1.16M 1.13M 1.47M 1.42M 1.26M 1.13M 682.97K 601K 635.74K
Stock-Based Compensation
2.82M 3.65M 3.79M 3.34M 4.2M 3.58M 3.7M 3.74M 3.77M 3.93M 3.8M 3.81M 3.79M 6.04M 6.2M 5.95M 6.01M 4.61M
Other Working Capital
-29.06K -1.98M -1.35M 239.27K 29.65K 1.19M 1.73M 3,249B 3,249B 3,249B 3,249B 2.8M 2.81M 3.18M 2.94M -1,107.4B -1,107.4B -1,107.4B
Other Non-Cash Items
-5.17M 814.1K 3.88M -1.43M 894.27K 74.83K -700.24K -4.71M -1.5M -311.61K 1.74M 6.43M 4.21M 2.78M 1.69M 1.42M 462.19K 729.22K
Deferred Income Tax
n/a n/a n/a -2.3M -304.14K -536.04K -536.04K 1.76M -231.9K n/a n/a n/a n/a n/a 882.95K -332.28K -1.7M -2.5M
Change in Working Capital
625.84K -3.4M -3.4M -1.81M -2.92M -1.38M 2.36M 537.53K 961.13K 1.7M -3.56M -200.66K -1.11M -497.74K 641.9K -1.36M -3.73M 332.01K
Operating Cash Flow
-9.78M -13.06M -14.43M -18.49M -21.24M -23.38M -21.66M -20.59M -22.12M -23.22M -28.23M -28.39M -25.78M -19.78M -14.01M -9.57M -8.72M -4.75M
Capital Expenditures
-506.66K -589.65K -669.43K -681.16K -640.52K -311.21K -867.07K -937.23K -1.4M -6.29M -6.46M -7.92M -8.22M -4.52M -4.28M -2.87M -2.26M -1.77M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-246.75K -348.38K -303.26K -248.25K -101.64K -69.16K -242.38K -235.02K -311.79K -403.71K -368.21K -515.89K -565.05K -600.03K -640.01K -603.82K -652.18K -872.51K
Investing Cash Flow
-601.55K -589.65K -669.43K -681.16K -640.52K -380.37K -936.24K -1.01M -1.47M -6.29M -6.46M -7.92M -8.22M -4.52M -4.28M -2.87M -2.26M -1.77M
Debt Repayment
-9.42M 567.42K -57.58K 9.3M 9.36M -625K n/a n/a n/a n/a n/a n/a n/a n/a n/a -15M -15M -15M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -40.36K -40.36K -40.36K -40.36K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
10.8M 10.65M 9.21M -145.03K -129.1K 175.73K 218.28K 5.21M 5.2M 5.04M 4.96M -121.28K 468.44K 598.29K 715.2K 421.12K 11.16K 845.38K
Financial Cash Flow
6.9M 16.73M 9.33M 21.37M 22.12M 13.22M 14.47M 7.26M 6.62M 5.68M 4.96M -121.28K 468.44K 598.29K 715.2K -14.35M 41.44M 48.54M
Net Cash Flow
-3.22M 3.02M -5.85M 2.12M 103.68K -10.64M -8.22M -14.19M -17.01M -23.97M -29.99M -36.8M -33.76M -23.76M -17.6M -26.94M 30.5M 42.08M
Free Cash Flow
-10.29M -13.65M -15.1M -19.17M -21.88M -23.69M -22.52M -21.53M -23.51M -29.51M -34.69M -36.31M -34.01M -24.3M -18.29M -12.45M -10.98M -6.52M